Search > Results
You searched for: EV220065 (EV-TRACK ID)
Showing 1 - 2 of 2
Showing 1 - 2 of 2
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV220065 | 1/2 | Bos taurus | Blood plasma |
DG (d)(U)C Filtration |
Crookenden MA | 2016 | 29% | |
Study summaryFull title
All authors
Crookenden MA, Walker CG, Peiris H, Koh Y, Heiser A, Loor JJ, Moyes KM, Murray A, Dukkipati VSR, Kay JK, Meier S, Roche JR, Mitchell MD
Journal
J Dairy Sci
Abstract
Biomarkers that identify prepathological disease could enhance preventive management, improve animal (show more...)
EV-METRIC
29% (59th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Blood plasma
Sample origin
Low risk metabolic disease
Focus vesicles
exosome
Separation protocol
Separation protocol
Density gradient
(Differential) (ultra)centrifugation Filtration Protein markers
EV: None
non-EV: None Proteomics
yes
Show all info
Study aim
Biomarker
Sample
Species
Bos taurus
Sample Type
Blood plasma
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 800 g and 10,000 g
Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: speed (g)
100000
Wash: volume per pellet (ml)
30
Wash: time (min)
75
Wash: speed (g)
100000
Density gradient
Type
Discontinuous
Sample volume (mL)
0.5
Orientation
Top-down
Fraction processing
Centrifugation
Pelleting: duration (min)
120
Pelleting: speed (g)
100000
Filtration steps
0.22µm or 0.2µm
Characterization: Protein analysis
Protein Concentration Method
Other/ DC protein assay
Proteomics database
No
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Not Reported
EV concentration
Yes
Particle yield
as number of particles per milliliter of starting sample
|
||||||||
EV220065 | 2/2 | Bos taurus | Blood plasma |
DG (d)(U)C Filtration |
Crookenden MA | 2016 | 29% | |
Study summaryFull title
All authors
Crookenden MA, Walker CG, Peiris H, Koh Y, Heiser A, Loor JJ, Moyes KM, Murray A, Dukkipati VSR, Kay JK, Meier S, Roche JR, Mitchell MD
Journal
J Dairy Sci
Abstract
Biomarkers that identify prepathological disease could enhance preventive management, improve animal (show more...)
EV-METRIC
29% (59th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
Blood plasma
Sample origin
High risk metabolic disease
Focus vesicles
exosome
Separation protocol
Separation protocol
Density gradient
(Differential) (ultra)centrifugation Filtration Protein markers
EV: None
non-EV: None Proteomics
yes
Show all info
Study aim
Biomarker
Sample
Species
Bos taurus
Sample Type
Blood plasma
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Between 800 g and 10,000 g
Between 10,000 g and 50,000 g Between 100,000 g and 150,000 g Pelleting performed
Yes
Pelleting: speed (g)
100000
Wash: volume per pellet (ml)
30
Wash: time (min)
75
Wash: speed (g)
100000
Density gradient
Type
Discontinuous
Sample volume (mL)
0.5
Orientation
Top-down
Fraction processing
Centrifugation
Pelleting: duration (min)
120
Pelleting: speed (g)
100000
Filtration steps
0.22µm or 0.2µm
Characterization: Protein analysis
Protein Concentration Method
Other/ DC protein assay
Proteomics database
No
Characterization: Lipid analysis
No
Characterization: Particle analysis
NTA
Report type
Not Reported
EV concentration
Yes
Particle yield
as number of particles per milliliter of starting sample: 3.74e+10
|
||||||||
1 - 2 of 2 |
EV-TRACK ID | EV220065 | |
---|---|---|
species | Bos taurus | |
sample type | Blood plasma | |
condition | Low risk metabolic disease | High risk metabolic disease |
separation protocol | Density gradient/ dUC/ Filtration | Density gradient/ dUC/ Filtration |
Exp. nr. | 1 | 2 |
EV-METRIC % | 29 | 29 |